129 related articles for article (PubMed ID: 25217796)
1. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis.
Templeton AJ; Diez-Gonzalez L; Ace O; Vera-Badillo F; Seruga B; Jordán J; Amir E; Pandiella A; Ocaña A
Cancer Treat Rev; 2014 Oct; 40(9):1048-55. PubMed ID: 25217796
[TBL] [Abstract][Full Text] [Related]
2. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
[TBL] [Abstract][Full Text] [Related]
4. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
[TBL] [Abstract][Full Text] [Related]
6. Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
Bartlett JM; Munro A; Cameron DA; Thomas J; Prescott R; Twelves CJ
J Clin Oncol; 2008 Nov; 26(31):5027-35. PubMed ID: 18768436
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry.
Lei X; Zhang Y; Mao L; Jiang P; Huang Y; Gu J; Tai N
Front Oncol; 2022; 12():819051. PubMed ID: 36212475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.
Zhu X; Zhang F; Zhang W; He J; Zhao Y; Chen X
J Surg Oncol; 2013 Nov; 108(6):387-97. PubMed ID: 24038070
[TBL] [Abstract][Full Text] [Related]
9. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer.
Müller-Tidow C; Diederichs S; Bulk E; Pohle T; Steffen B; Schwäble J; Plewka S; Thomas M; Metzger R; Schneider PM; Brandts CH; Berdel WE; Serve H
Cancer Res; 2005 Mar; 65(5):1778-82. PubMed ID: 15753374
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
Tari AM; Hung MC; Li K; Lopez-Berestein G
Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
Zhao S; Liu Y; Zhang Q; Li H; Zhang M; Ma W; Zhao W; Wang J; Yang M
Breast Cancer Res Treat; 2011 Dec; 130(3):809-16. PubMed ID: 21311967
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
[TBL] [Abstract][Full Text] [Related]
13. EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.
Kallel I; Khabir A; Boujelbene N; Abdennadher R; Daoud J; Frikha M; Aifa S; Sallemi-Boudawara T; Rebaï A
J Recept Signal Transduct Res; 2012 Jun; 32(3):142-9. PubMed ID: 22394363
[TBL] [Abstract][Full Text] [Related]
14. Expression of activated type I receptor tyrosine kinases in early breast cancer.
Spears M; Pederson HC; Lyttle N; Gray C; Quintayo MA; Brogan L; J Thomas JS; Kerr GR; Jack WJ; Kunkler IH; Cameron DA; Chetty U; Bartlett JM
Breast Cancer Res Treat; 2012 Jul; 134(2):701-8. PubMed ID: 22562124
[TBL] [Abstract][Full Text] [Related]
15. Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer.
Tevaarwerk AJ; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2332-48. PubMed ID: 20110044
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
Chia S; Norris B; Speers C; Cheang M; Gilks B; Gown AM; Huntsman D; Olivotto IA; Nielsen TO; Gelmon K
J Clin Oncol; 2008 Dec; 26(35):5697-704. PubMed ID: 19001334
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.
Blanckaert VD; Hebbar M; Louchez MM; Vilain MO; Schelling ME; Peyrat JP
Clin Cancer Res; 1998 Dec; 4(12):2939-47. PubMed ID: 9865904
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells.
Montero JC; Seoane S; Pandiella A
Cell Signal; 2013 Nov; 25(11):2281-9. PubMed ID: 23899556
[TBL] [Abstract][Full Text] [Related]
19. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.
Hsu JL; Hung MC
Cancer Metastasis Rev; 2016 Dec; 35(4):575-588. PubMed ID: 27913999
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.
Hong L; Han Y; Yang J; Zhang H; Jin Y; Brain L; Li M; Zhao Q
Gene; 2013 Oct; 529(1):69-72. PubMed ID: 23954221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
